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Abstract
Purpose To analyze whether the T1 relaxation time of the liver is a good predictor of significant liver fibrosis and whether
normalization to the blood pool improves the predictive value.
Methods This prospective study was conducted between 03/2016 and 02/2018. One hundred seventy-three patients underwent
multiparametric liver MRI at 3 T. The T1 relaxation time was measured in the liver and the spleen, in the aorta, the portal vein,
and the inferior vena cava (IVC). T1 relaxation times with and without normalization to the blood pool were compared between
patients with (n = 26) and without (n = 141) significant liver fibrosis, based on a cutoff value of 3.5 kPa in MRE as the
noninvasive reference standard. For statistics, Student’s t test, receiver operating characteristic (ROC) curve analysis, and
Pearson’s correlation were used.
Results The T1 relaxation time of the liver was significantly longer in patients with liver fibrosis, both with and without blood
pool normalization (p < 0.001). T1 relaxation time of the liver allowed prediction of significant liver fibrosis (AUC= 0.88), while
normalization to the IVC resulted in a slightly lower performance (AUC = 0.82). The lowest performance was achieved when the
T1 relaxation times of the liver were normalized to the aorta (AUC= 0.66) and to the portal vein (AUC= 0.62). The T1 relaxation
time of the spleen detected significant liver fibrosis with an AUC of 0.68, and 0.51–0.64 with normalization to the blood pool.
Conclusion The T1 relaxation time of the liver is a good predictor of significant liver fibrosis. However, normalization of the
blood pool did not improve the predictive value.
Key Points
• The T1 relaxation time of the liver is a good predictor of significant liver fibrosis.
• Normalization to the blood pool did not improve the predictive value of T1 mapping.
• If the blood pool normalization was weighted 30% to the aorta and 70% to the portal vein, the performance was better than
normalization to the aorta alone but still lower than normalization to the IVC.
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PDFF Proton density fat fraction
ROC Receiver operating characteristics
ROI Region of interest
Introduction
The prognosis and management of chronic liver disease (CLD)
depend strongly on the degree of liver fibrosis in all etiologies
[1]. Magnetic resonance elastography (MRE) allows accurate
assessment of liver fibrosis with low failure rates and coverage
of the whole liver volume [2, 3]. MRE therefore represents the
noninvasive reference standard for the assessment of liver fi-
brosis [4, 5]. One major advantage of MRE is the possibility of
combining it with other magnetic resonance imaging (MRI)
sequences for liver fat [6, 7] and iron quantification [8] as a
one-stop shop. However, MRE equipment is expensive and not
yet widely available. A more widely available MRI sequence
would therefore be very helpful to detect significant liver fibro-
sis without the need for expensive additional hardware or time-
consuming image post-processing.
One very promising quantitative MRI sequence to do so is
T1 mapping. It allows quantification of the T1 relaxation time
of the liver and spleen [9, 10] and may be acquired within one
breath-hold per slice without the need for any additional hard-
ware or time-consuming image post-processing. Recently, re-
searchers showed that the T1 relaxation time of the liver is
significantly longer in patients with liver fibrosis [11, 12].
Other studies demonstrated a longer T1 relaxation time of
the spleen in patients with significant portal hypertension [13].
However, T1 is influenced by the patient’s hematocrit [14,
15], blood oxygenation [16], and amount of blood pool [17].
Even if large vessels are excluded from the region of interest
(ROI), their value always represents a mix of T1 relaxation
times of the liver parenchyma, bile ducts, and blood pool, in-
cluding afferent arterial and portal vein vessels, liver sinusoids,
and efferent liver veins. Since we are mainly interested in the
T1 relaxation time of the liver parenchyma, it might be helpful
to minimize the effects of the liver blood pool by normalizing it
to the inferior vena cava (IVC), to the portal vein, or to the aorta.
The aim of this study was to analyze whether the T1 relax-
ation time of the liver is a good predictor of significant liver
fibrosis and whether normalization to the blood pool improves
the predictive value using MRE as a reference standard.
Method and materials
Study population
This prospective study was approved by the institutional re-
view board (Kantonale Ethikkommission Bern, IRB number
282-15) and was conducted after obtaining written patient
informed consent. All consecutive patients undergoing liver
CT and liver MRI with MRE in our institution between 03/
2016 and 02/2018 were included in the study. Based on CT
images, patients without prior liver surgery, solid liver lesions,
or portal vein thrombosis were selected. A total of 173 patients
thus underwent multiparametric liver MRI at 3 T, including T1
mapping, proton density fat fraction (PDFF) quantification, and
gradient echo–based MRE. Six patients were excluded because
of an incomplete MR exam due to claustrophobia (n = 1), iron
overload (n = 1), heart failure (n = 1), or technical failure of
MRE (n = 3) (Fig. 1). There were no further specific inclusion
criteria to ensure to cover the entire spectrum from patients
without known liver disease to those with no and mild liver
fibrosis as well as those patients with advanced liver fibrosis
and know cirrhosis. Patients were divided into two groups with
and without significantly elevated liver stiffness using a cutoff
value of 3.5 kPa in MRE (corresponding to F2 or higher in
histology) [18]. A total of 141 patients had a liver shear modulus
< 3.5 kPa, while 26 patients had a liver shear modulus ≥ 3.5 kPa.
Clinical information and laboratory test results were recorded.
Clinical parameters included age, sex, body mass index (BMI),
history of diabetes or hypertension, daily drug intake, tobacco
use, and alcohol consumption. Biological parameters included
dyslipidemia, platelet count, quick value, total bilirubin levels,
gamma-glutamyl transpeptidase (GGT), aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), alkaline phos-
phatase, albumin, creatinine, and hematocrit.
MR imaging technique
All liver exams were performed on a 3-T MR system (Verio,
Siemens Healthineers) in a fasting state (> 6 h) including T1-
and T2-weighted sequences, T1 relaxometry, and MRE. For T1
relaxometry, three single breath-hold (11 ms) axial slices were
acquired in the liver using a MOLLI sequence with a 3-3-5
design. ECG was simulated by pulse triggering on the patient’s
fingertip. The following parameters were used: repetition time
(TR) of 740 ms, echo time (TE) of 1.01 ms, inversion time (TI)
of 225 ms (3 inversion pulses, at 65 ms, 145 ms, and 225 ms),
and flip angle (FA) of 35°. The slice thickness was 8 mm, the
field-of-view (FOV) was 308 × 384 mm, and the matrix was
154 × 192 pixels. For MRE, a gradient echo–based MRE se-
quence (WIP package 622 provided by Siemens Healthineers)
was used. A pneumatic driver (Resoundant®) was placed on the
right upper quadrant of the abdomen, transmitting shear waves
by continuous acoustic vibrations with a frequency of 60 Hz.
Three single-slice acquisitions with 5-mm slice thicknesses were
performed on the same level as T1 maps.
MR imaging analysis
For imaging analysis, regions of interest (ROIs) were drawn in
the right liver lobe by an experienced radiologist (V.O., 8 years
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of experience in hepatic imaging) on T1 maps, as well as on
MRE 95% confidence stiffness maps. ROIs on T1 maps were
drawn in every liver segment that was visualized in good
image quality with a minimal distance of 5 mm to the liver
border and to large blood vessels to avoid partial volume
effects, with a mean ROI size of 209 pixels. Measurements
from all liver segments were then averaged in every patient.
Liver areas adjacent to the lung were avoided to exclude air
susceptibility effects (10). The T1 relaxation time was mea-
sured in the right lobe of the liver and in the spleen, as well as
in the aorta, in the portal vein, and in the inferior vena cava
(IVC). All vessel measurements were made on the same
level of the liver hilus on the level of the portal vein bifur-
cation. Liver stiffness was measured in the right liver lobe
only (Fig. 2). ROIs on MRE stiffness maps were drawn in
the liver in the 95% confidence region, which is shown
without crosshairs on the map, with a ROI size of 4382 ±
2234 pixels. Measurements from three slices were then av-
eraged to generate the patients’ liver stiffness value. A
shear modulus ≥ 3.5 kPa was defined as significant liver
fibrosis (corresponding to histology fibrosis stage ≥ F2)
[3, 19, 20].
Statistical analysis
Analysis was performed with the statistical software package
R (version 3.4.1, R Foundation for Statistical Computing) [21]
and GraphPad Prism (version 7.1, GraphPad Software Inc.).
Clinical characteristics were compared between groups using
the Wilcoxon test for continuous variables or Fisher’s exact
test for categorical variables. The level of significance was
p < 0.05. MRE liver stiffness was compared with T1
relaxation times alone, as well as T1 relaxation times normal-
ized to the blood pool in the IVC, in the portal vein, in the
aorta, and in the spleen. For normalization to the blood pool,
T1 relaxation times of the liver were divided by the T1 relax-
ation times of the blood pool. Since the liver has a dual arterial
and venous blood supply, T1 relaxation times were also nor-
malized to the blood pool weighted 30% for the aorta and 70%
for the portal vein. To investigate the usefulness of different
T1 relaxometry values to predict significant liver fibrosis,
Pearson correlation, Student’s t test, and receiver operating
characteristic (ROC) curve analysis were used. Cutoff values
were calculated based on the Youden index. For the purpose
of assessing the interrater reliability of T1 measurements, T1
relaxation times of the liver, aorta, portal vein, IVC, and
spleen were remeasured by a second reader (D.C., 1 year of
experience with hepatic imaging) in twenty patients: ten pa-
tients who were randomly selected with a shear modulus <
3.5 kPa and 10 patients who were randomly selected with a
shear modulus ≥ 3.5 kPa. The intraclass correlation coefficient
(ICC) was then calculated, and ICC classifications of 0.4–0.59
were considered fair, 0.6–0.74 were considered good, and
0.75–1.00 were considered excellent [22].
Results
Patient characteristics
The patient characteristics are shown in Table 1. Patients
with elevated liver stiffness (shear modulus ≥ 3.5 kPa)
showed higher frequencies of daily tobacco and alcohol
consumption, higher liver enzymes (AST: 46 ± 22 vs. 28
Fig. 1 Patient flowchart. A total
of 173 patients without prior liver
surgery, solid liver lesions, or
portal vein thrombosis underwent
multiparametricMRI. Six patients
have been excluded due to
technical failure of MRE (n = 3),
claustrophobia (n = 1), heart
failure (n = 1), or iron overload
(n = 1) resulting in an included
study population of 167 patients
which could be divided into 141
patients with a liver shear
modulus < 3.5 kPa and 26
patients ≥ 3.5 kPa). MRE,
magnetic resonance elastography
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± 18, p value < 0.004 and GGT: 140 ± 91 vs. 39 ± 40,
p value < 0.001), and bilirubin (22 ± 18 vs. 9 ± 6, p value
0.004), as well as lower thrombocytes (158 ± 100 vs. 245
± 86, p = 0.006) and Quick value (77 ± 17 vs. 96 ± 12, p
value < 0.001), compared to those of patients with a liver
shear modulus < 3.5 kPa. There was no significant differ-
ence in BMI between the groups (29 ± 7 vs. 26 ± 7, p =
0.12).
According to MRE as the reference standard, 103 pa-
tients had a liver shear modulus of less than 2.5 kPa,
corresponding to normal liver stiffness; 23 patients had
a liver shear modulus of 2.5 to ≤ 2.9, corresponding to
normal or inflammation; and 15 patients had a liver shear
modulus 2.9 to ≤ 3.5 kPa (F1–2), 5 patients 3.5 to ≤
4.0 kPa (F2–3), 8 patients 4.0 to ≤ 5.0 kPa (F3–4), and
13 patients more than 5.0 kPa (F4) using cutoffs as de-
scribed by Srinivasa et al [3].
Of the 26 patients with elevated liver stiffness (shear mod-
ulus ≥ 3.5 kPa), 23 had known liver fibrosis (1 patient with a
histology fibrosis stage F1, 2 patients with F2, 6 patients with
F3, and 14 patients with F4 in histology or clinically
established diagnosis of liver cirrhosis), while chronic liver
disease was not known in 3 patients who were lost to
follow-up (1 patient with metabolic syndrome and 2 patients
with cancer without liver metastasis). The etiology of liver
disease in patients with elevated liver stiffness was viral hep-
atitis (n = 9), alcohol-induced liver disease (n = 10), NAFLD/
NASH (n = 3), and cryptogenic liver cirrhosis (F4) in histolo-
gy in 1 patient and unknown in the 3 patients who were lost to
follow-up, as described above (Table 2).
Of the 141 patients without elevated liver stiffness (shear
modulus < 3.5 kPa), 4 had liver biopsy with a diagnosis of
NAFLD/NASH (1 patient with a histology fibrosis stage F2, 2
patients with F1, and 1 patient with F0), 5 patients had chronic
Fig. 2 Patient example. Images from a 47-year-old female patient with
chronic hepatitis C and liver fibrosis F3 in histology. T2w HASTE se-
quence (a) is shown for anatomical orientation on the same slice as the T1
mapping (b) andMREwave image (c) and stiffness map (d). ROIs on the
T1 map are drawn in the liver (mean 947 ms), spleen (1462 ms), portal
vein (1781 ms), IVC (1899 ms), and aorta (1972 ms). The liver T1
relaxation time (mean 947 ms) and stiffness (4.4 kPa) are both elevated.
HASTE, half-Fourier single-shot turbo spin-echo; MRE, magnetic reso-
nance elastography; ROI, region of interest; IVC, inferior vena cava
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viral hepatitis without known liver fibrosis, while the remain-
ing 132 patients had no known chronic liver disease. In pa-
tients with significantly elevated liver stiffness (shear modulus
≥ 3.5 kPa, corresponding to a liver fibrosis stage f2 or higher),
19/26 patients (73%) had liver steatosis (PDFF ≥ 5%), while
10/26 patients (38%) had moderate to severe liver steatosis
(PDFF ≥ 15%). In patients without significantly elevated liver
stiffness (shear modulus < 3.5 kPa), 102/141 patients (73%)
had liver steatosis (PDFF ≥ 5%), while 19/141 patients (13%)
had moderate or severe liver steatosis (PDFF ≥ 15%).
Table 1 Patient characteristics
Liver shear modulus
< 3.5 kPa
n Liver shear modulus
≥ 3.5 kPa
n p value
Age, years 50 ± 15 141 59 ± 9 26 < 0.001
Male, % 72 (51%) 141 15 (58%) 26 0.404
Shear modulus, kPa 2.23 ± 0.49 141 6.01 ± 3.34 26 < 0.001**
Tobacco, n (%) 25 (18%) 138 15 (60%) 25 < 0.001**
Daily alcohol
consumption, n (%)
13 (9%) 140 17 (68%) 25 < 0.001**
Diabetes, n (%) 10 (10%) 96 7 (30%) 23 0.005*
Hypertension, n (%) 29 (21%) 138 12 (48%) 25 0.016
BMI, kg/m2 26 ± 7 137 29 ± 7 22 0.120
PDFF, % 11 ± 8 141 13 ± 11 26 0.427
AST, U/l 28 ± 18 56 46 ± 22 20 < 0.004*
ALT, U/l 39 ± 50 74 39 ± 23 20 0.965
GGT, U/l 39 ± 40 65 140 ± 91 21 < 0.001**
Alkaline phosphatase, U/l 74 ± 30 57 102 ± 48 19 0.021*
Bilirubin, μmol/l 9 ± 6 51 22 ± 18 21 0.004*
Albumin 35 ± 7 43 34 ± 7 21 0.224
Thrombocytes 245 ± 86 35 158 ± 100 16 0.006*
Quick, % 96 ± 12 64 77 ± 17 21 < 0.001**
APRI 0.4 ± 1.1 34 1.7 ± 2.0 15 0.032*
Creatinine, μmol/l 79 ± 20 93 80 ± 23 23 0.914
Values are the mean ± SD or n. p values were calculated using the Mann-Whitney U or Fisher’s exact test, as
appropriate. Comparisons between the two patient groups are indicated with * if p < 0.05 and ** if p < 0.001
BMI, body mass index; PDFF, proton density fat fraction; AST, aspartate aminotransferase; ALT, alanine amino-
transferase; GGT, gamma-glutamyl transferase; APRI, aspartate aminotransferase-to-platelet ratio index
Table 2 Etiology of chronic liver
disease in the study population Etiology Liver shear modulus < 3.5 kPa
(n = 141)
Liver shear modulus ≥ 3.5 kPa
(n = 26)
Viral hepatitis N = 5 (without known fibrosis) N = 9
ALD N = 0 N = 10
NAFLD/NASH N = 4 (1 F0; 2 F1; 1 F2) N = 3
Cryptogenic cirrhosis N = 0 N = 1
Unknown reason/lost for FU N = 0 N = 3
No known liver disease N = 132 N = 0
In 26 patients with a liver shear modulus ≥ 3.5 kPa (corresponding to a liver fibrosis stage f2 or higher), most
prevalent etiology of chronic liver disease was viral hepatitis (n = 9) and ALD (n = 10). Of 141 patients with a
liver shear modulus < 3.5 kPa, 132 had no known chronic liver disease. The remaining 9 patients with chronic
liver disease had viral hepatitis without fibrosis (n = 5) or NAFLD/NASH without significant fibrosis (n = 4)
ALD, alcoholic liver disease; NAFLD/NASH, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis; FU,
follow-up
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T1 mapping results
T1 relaxation time in the liver, both with and without blood
pool normalization, was significantly longer in patients with a
liver shear modulus ≥ 3.5 kPa compared to those with a liver
shear modulus < 3.5 kPa (943 ± 114 ms and 781 ± 90 ms,
p < 0.001). T1 relaxation time in the spleen was significantly
longer in patients with elevated liver stiffness as well (1296 ±
130 ms and 1220 ± 109 ms, p = 0.011), although the differ-
ences were smaller than for the T1 relaxation time of the liver
(Table 3). In the Pearson analysis, longer T1 relaxation times
of the liver correlated well with higher liver shear modulus
(r = 0.59, p < 0.001), while relaxation times of the liver nor-
malized to the blood correlated less with higher liver shear
modulus (r = 0.2–0.46, p < 0.001–0.06) (Table 4). Although
fat is a known confounding factor of T1 relaxation time [23],
correlation between T1 relaxation times and PDFF was weak
(r = 0.34, p < 0.001), while correlation of T1 with MRE was
much better (r = 0.59, p < 0.001). Interestingly, the scatterplot
shows that patients with higher PDFF also tend to have high
liver stiffness as an indicator of coexisting inflammation and/
or fibrosis (Fig. 3). The correlation between higher liver stiff-
ness and longer T1 time of the spleen was rather low (r = 0.23,
p = 0.004).
ROC analysis
The ROC analysis (Fig. 4) confirmed the good performance of
T1 relaxation times of the liver to separate patients with a liver
shear modulus < 3.5 kPa and patients with a liver shear
modulus ≥ 3.5 kPa (AUC= 0.88). The different cutoff values
based on the Youden index are shown in Fig. 4. For T1 relax-
ation time of the liver, two cutoff values are shown. The
higher cutoff value of > 890 ms is optimized using the
Youden index, with a specificity of 92% and a sensitivity
of 73% for significant liver fibrosis. The lower cutoff of
> 825 ms is optimized for high sensitivity with a specific-
ity of 73% and a specificity 85%. When the T1 relaxation
time of the liver was normalized to the blood pool, the
best performance was obtained when normalizing to the
IVC (AUC = 0.82), while the performance of T1 relaxa-
tion times normalized to a mixed arterial and portal ve-
nous pool with a weighting of 30%:70% was lower
(AUC = 0.67). The lowest performance was achieved
when the T1 relaxation times of the liver were normalized
to the aorta (AUC = 0.66) and the portal vein (AUC =
0.62). The T1 relaxation times of the spleen allowed a
discrimination of the two patient groups with an AUC =
0.68, while normalization of the T1 relaxation times of the
spleen to the blood pool showed slightly lower perfor-
mance (AUC = 0.51–0.64, p = 0.03 for IVC and p =
0.831 for aorta normalization).
Robustness of the measurements and interreader
reliability
T1 relaxation times of the liver were measured in all 167
patients. While aortic and IVC measurements were possible
in 95% and 98%, the portal vein was captured in only 55% of
the patients on T1 maps (Table 5). T1 mapping of the spleen
Table 3 Comparison of T1
relaxation times in patients with
and without significant liver
fibrosis
Liver shear modulus
< 3.5 kPa
n Liver shear modulus
≥ 3.5 kPa
n p value
T1 liver, ms 781 ± 90 141 943 ± 114 26 < 0.001**
T1 spleen, ms 1221 ± 109 130 1296 ± 130 25 0.003*
T1 aorta, ms 1609 ± 683 133 1628 ± 336 25 0.835
T1 cava, ms 1639 ± 180 140 1645 ± 202 24 0.886
T1 liver/cava 0.48 ± 0.07 140 0.58 ± 0.09 24 < 0.001**
T1 liver/aorta 0.51 ± 0.10 133 0.61 ± 0.17 25 < 0.001**
T1 liver/portal vein 0.50 ± 0.06 82 0.52 ± 0.07 10 0.259
T1 liver/aorta and portal vein
(30%/70%)
0.50 ± 0.07 77 0.53 ± 0.07 10 0.130
T1 liver/spleen 0.64 ± 0.07 130 0.73 ± 0.09 25 < 0.001**
T1 spleen/cava 0.75 ± 0.10 129 0.80 ± 0.10 24 0.044*
T1 spleen/aorta 0.80 ± 0.16 122 0.83 ± 0.22 25 0.350
T1 spleen/aorta and cava
(50%/50%)
0.78 ± 0.13 123 0.81 ± 0.11 24 0.293
T1 spleen/aorta and cava
(30%/70%)
0.78 ± 0.20 123 0.80 ± 0.10 24 0.393
Values are the mean ± SD or n. p values were calculated using Student’s t test
Comparisons between the two patient groups are indicated with * if p < 0.05 and ** if p < 0.001
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Fig. 3 Scatterplots and correlation analysis. Scatterplots illustrate the
relationship between MRE, T1, and PDFF in a and b. For better
visualization, c and d represent enlarged views of a and b. In b and d,
patients were color-coded to reflect the degree of their underlying liver
stiffness based on MRE. MRE, magnetic resonance elastography; PDFF,
proton density fat fraction
Table 4 Pearson correlation
between T1 values and liver
stiffness
Pearson correlation r p value
T1 liver, ms 0.59 < 0.001**
T1 spleen, ms 0.23 0.004*
T1 liver/cava 0.45 < 0.001**
T1 liver/aorta 0.43 < 0.001**
T1 liver/spleen 0.46 < 0.001**
T1 liver/portal vein 0.20 0.058
T1 liver/aorta and portal vein (30%/70%) 0.36 < 0.001**
T1 liver/spleen 0.46 < 0.001**
T1 spleen/cava 0.11 0.165
T1 spleen/aorta 0.15 0.080
Values represent the Pearson correlation coefficient with the corresponding p values. Comparisons between the
two patient groups are indicated with * if p < 0.05 and ** if p < 0.001
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was measured and of good quality in 155 patients, not mea-
surable in 5 patients, and 7 patients had a post-splenectomy
status. Interobserver reliability within our group was excellent
for all measurements (ICC = 0.84–0.97), except for the mea-
surements for the T1 ratio in the liver to the aorta and portal
vein (ICC = 0.74), which were slightly lower.
Discussion
This is the first study to demonstrate that the T1 relaxation
time of the liver is significantly longer in patients with liver
fibrosis, both with and without blood pool normalization.
Overall, the T1 relaxation time of the liver without blood pool
normalization was the best predictor of significant liver fibro-
sis, based on an MRE cutoff value of 3.5 kPa or higher [24].
With blood pool normalization, better results were observed in
the IVC than in the portal vein and in the aorta. Measurements
were more difficult in the portal vein than in the IVC and in
the aorta due to its horizontal course through the acquired
slices [25]. Unlike the IVC and the aorta, the portal vein was
not always captured and was prone to partial volume effects.
The blood pool in the vena cava is probably more similar to
the blood pool in the liver sinusoids, than the blood pool in the
aorta. This might explain why the normalization of T1 relax-
ation times to the vena cava showed better results than nor-
malization to the aorta. Interestingly, normalization to a com-
bined mean value of the aorta and portal vein resulted in better
results with a higher specificity than normalization to the aorta
or the portal vein alone. This indicates that blood pool nor-
malization works better, the closer we get to the T1 relaxation
times of the liver sinusoids. Another important confounder of
normalization to the aorta and to the portal vein might be the
different afferent vascularization of the liver, with an arterial
portion of approximately 30% in a normal liver, which in-
creases significantly in liver fibrosis [26], as well as flow
phenomenon in the aorta influencing the measured T1 relax-
ation time. Whether adapting the arterial portion in relation to
the degree of fibrosis or angled, orthogonal acquisitions of T1
maps to the portal vein might increase the predictive value
should be investigated in a subsequent study.
Our results are in line with the findings of other groups,
who have shown that liver T1 relaxation time is a good pre-
dictor of fibrosis [11, 12, 27, 28] and may even predict clinical
outcome [29]. Yoon et al published T1 relaxation times of the
Table 5 Robustness of the
measurements and intraclass
correlation coefficient for T1
relaxation times
N < 3.5 kPa N ≥ 3.5 kPa N total % ICC
T1 liver 141 26 167 100 0.97
T1 liver and cava 140 24 164 98 0.92
T1 liver and aorta 133 25 158 95 0.86
T1 liver and portal vein 82 10 92 55 0.91
T1 liver and aorta and portal vein 77 10 87 52 0.74
T1 liver and spleen 130 25 155 93 0.86
T1 spleen 130 25 155 93 0.92
T1 spleen and cava 129 24 153 92 0.91
T1 spleen and aorta 122 25 147 88 0.85
Values are the number of patients in which T1 measurements could be performed with excellent quality. The
intraclass correlation coefficient (ICC) between both readers is noted
Fig. 4 ROC analysis. ROC curves for the T1mapping results of the liver,
as well as those normalized to the cava, aorta, and portal vein,
distinguishing between patients with and without elevated liver stiffness
(shear modulus < 3.5 kPa vs. ≥ 3.5 kPa), are shown. AUC values as well
as the number of measurements are indicated. ROC, receiver operating
characteristics; AUC, area under the ROC curve
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liver between 879 and 1042 ms in patients with liver cirrhosis
and different Child-Pugh scores [30], which is in the same
range as measured in our patients. Other studies investigated
T1 relaxation time of the liver normalized to the skeletal mus-
cles [31]. However, to our knowledge, this is the first study
investigating the T1 relaxation time of the liver normalized to
the blood pool in the IVC, in the aorta, and in the portal vein.
The T1 relaxation time of the spleen was significantly lon-
ger in patients with liver fibrosis, but the difference between
patients with and without liver fibrosis was much smaller in
the spleen than in the liver. This observation was confirmed by
ROC analysis. A probable explanation for the higher T1 re-
laxation time of the spleen in patients with significant liver
fibrosis is portal hypertension with subsequent splenic con-
gestion. For the detection of significant fibrosis using splenic
parameters, splenic volumetry has an AUC of 0.83 [32], and
the 2D diameter of the interpole distance has an AUC of 0.88
[33], both of which are higher than splenic T1 mapping (AUC
0.68). Levick et al showed that a longer T1 relaxation time of
the spleen correlated with an increasing hepatic venous pres-
sure gradient (HVPG) [13]. However, this might be masked
by Gamna-Gandy bodies in the spleen in patients with portal
hypertension, which would shorten the T1 relaxation time
[34]. The same phenomenon may be observed when measur-
ing significantly increased splenic stiffness in patients with
increasing degrees of liver fibrosis [35, 36]. Another study
from Reiter et al has demonstrated a correlation between
splenic stiffness and the degree of liver fibrosis in multifre-
quency tomoelastography. The combination of hepatic and
splenic shear wave speed resulted in an even higher prediction
for liver fibrosis, while the best prediction was achieved with
60 Hz [37].
T1 relaxation time measurements of the liver and spleen
were very robust with excellent interreader reliability. When
normalizing the blood pool, measurements in the portal vein
were less robust and reproducible. Unlike the aorta and the
IVC, the portal vein was often not covered on the acquired
slices or showed partial volume effects due to its rather hori-
zontal course through the axial slices. To ensure high repro-
ducibility of the T1 relaxation time measurements of the liver,
the ROI should not be drawn within a distance of 5 mm to the
liver border and to large blood vessels to avoid partial volume
effects. Liver areas adjacent to the lung should be avoided
because of partial volume and susceptibility effects [10].
Nevertheless, even if those criteria are taken into account, it
is inevitable that smaller vessels and the blood pool in the liver
sinusoids are included in any liver ROI. The measured T1
relaxation time therefore represents a mix of tissue composi-
tion, bile ducts, and blood pool, including arteries, portal
veins, liver veins, and liver sinusoids.
As demonstrated in this study, the liver T1 relaxation time
is more influenced by the venous blood pool in the liver sinu-
soids than the blood in the dual afferent arterial and portal
venous vascular system. This might be of interest when T1
mapping with extracellular contrast medium is used to calcu-
late extracellular volume (ECV) fraction [38]. The ECV is
calculated as the difference of relaxation rates (R1 = 1/T1) of
the blood and liver parenchyma before and after intravenous
administration of an extracellular contrast medium, corrected
for the hematocrit. The initial results have shown that the ECV
fraction increases with the degree of liver fibrosis [39]. Based
on these findings, ECV calculation in the liver might be more
accurate when measured in the IVC and not in the aorta. This
makes sense since the blood hematocrit, used to calculate
ECV, is normally measured in a venous blood sample. A
comparison of different ECV values of the liver comparing
blood pool measurement in the aorta and in the IVC should be
investigated in upcoming studies.
There are several other confounders of T1 relaxation time
in the liver, including steatosis, inflammation, and portal hy-
pertension. Both inflammation and portal hypertension are
influencing liver stiffness in MRE as well, so a differentiation
is not possible with the current study design and should be
subject to further investigations. A higher degree of liver
steatosis, as measuredwith PDFF in this study, correlatedwith
a longer T1 relaxation time. However, patients with a high
degree of liver steatosis also showed higher degrees of liver
stiffness in MRE. This indicates coexistence of inflammation
and/or fibrosis in patients with significant liver steatosis.
There are several limitations of our study. First, we did not
perform liver biopsy in most patients because a large portion
of our patients did not have significant liver fibrosis. Hence,
our study population mirrors a daily routine patient spectrum
in a radiology department. MRE has been proven to reflect the
degree of liver fibrosis very accurately compared to histology
[2]. In addition, it covers the whole liver volume and not just a
1/40,000 volume of the liver with potential sampling errors in
histology (38, 39). Another limitation is the relatively small
proportion of patients with significantly elevated liver stiff-
ness compared to the bigger proportion of patients without
known liver disease and thus normal liver stiffness measure-
ments. Again, this reflects daily routine in a radiology depart-
ment where we intend to screen for liver fibrosis in a large
population, including patients without known liver fibrosis.
However, this skewed patient distribution might have resulted
in a consecutive overestimation of performance of T1 map-
ping of the liver itself while the main question of the study, the
impact of normalization to the blood pool, should not be sub-
stantially impacted.
Conclusion
The T1 relaxation time of the liver is a good predictor of
significant liver fibrosis. However, normalization to the blood
pool did not improve the predictive value.
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